We are live on ! Find out more
BI

Boulegeris Investments Portfolio holdings

AUM $200M
1-Year Est. Return 7%
This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+7%
3 Year Est. Return
+39.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136M
AUM Growth
+$10.1M
Cap. Flow
+$5.81M
Cap. Flow %
4.28%
Top 10 Hldgs %
62.09%
Holding
51
New
6
Increased
24
Reduced
15
Closed
3

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.96M
2
DIS icon
Walt Disney
DIS
+$1.09M
3
DHC
Diversified Healthcare Trust
DHC
+$754K
4
BIIB icon
Biogen
BIIB
+$618K
5
HD icon
Home Depot
HD
+$612K

Top Sells

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$1.93M
2
JNJ icon
Johnson & Johnson
JNJ
+$1.02M
3
PG icon
Procter & Gamble
PG
+$635K
4
LMT icon
Lockheed Martin
LMT
+$617K
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$511K

Sector Composition

Rank Sector Weight
1 Healthcare 23.5%
2 Real Estate 23.19%
3 Technology 11.57%
4 Consumer Staples 7.58%
5 Financials 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PG icon
51
Procter & Gamble
PG
$342B
– –
-6,969
Closed -$635K
1 2
3

Similar funds

ACM
AidennLair Capital Management New York $200M AUM 4.39% 1-Year Est. Return
SSM
Sutton Square Management New York $193M AUM
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
OA
Outfitter Advisors Mclean, Virginia $221M AUM 13.61% 1-Year Est. Return
XGI
XL Group Investments Hamilton, Bermuda $169M AUM 13.59% 1-Year Est. Return
MGA
MatlinPatterson Global Advisers New York $163M AUM 32.35% 1-Year Est. Return
MFP
Mosaic Financial Partners San Francisco, California $152M AUM 1.45% 1-Year Est. Return
ESG
Emerging Sovereign Group New York $252M AUM 22.55% 1-Year Est. Return

Boulegeris Investments's Q1 2015 Portfolio in Review

As of Q1 2015, Boulegeris Investments held 51 positions worth $136M, up 8% from $126M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Boulegeris Investments deployed $5.81M of net new capital in Q1 2015, opening 6 new positions and adding to 24 existing holdings. Its largest new stake was Allergan plc: 13,886 shares worth $4.13M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Real Estate and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.02M trimmed.

  • Boulegeris Investments's largest Q1 2015 buy was Allergan plc: 13,886 shares worth $4.13M.
  • Boulegeris Investments added most to Walt Disney in Q1 2015, an estimated $1.09M increase.
  • Boulegeris Investments's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $1.02M.
  • Boulegeris Investments fully exited Acadia Pharmaceuticals in Q1 2015, selling an estimated $1.93M.
  • Boulegeris Investments's ten largest holdings make up 62% of its $136M portfolio in Q1 2015.
  • Boulegeris Investments opened 6 new positions and closed 3 in Q1 2015.
  • Boulegeris Investments's portfolio value rose 8% quarter-over-quarter to $136M.

Based on Boulegeris Investments's 13F filing for Q1 2015, filed 12 May 2015.